文献速递乳腺乳腺X线MR

Kaiser评分在乳腺肿块对比增强乳腺X线摄影与磁共振成像中的诊断性能:一项比较研究

Diagnostic performance of the Kaiser score for contrast-enhanced mammography and magnetic resonance imaging in breast masses: A Comparative Study.
PubMed 文献 · Acad Radiol · 2024-10-11

研究纳入275例乳腺强化肿块患者,比较Kaiser评分(KS)在对比增强乳腺X线摄影(CEM)与MRI上的诊断效能。全部分析中CEM的KS的AUC为0.897~0.932,高于BI-RADS的0.691(均p<0.001);KS(钙化)-CEM的AUC为0.932,高于KS-CEM和KS(水肿)-CEM的0.897和0.899(均p<0.001)。结论认为CEM的KS诊断准确性与MRI相当。

要点

  • CEM的KS的AUC为0.897~0.932,高于BI-RADS的0.691(均p<0.001)。
  • KS(钙化)-CEM的AUC为0.932,高于KS-CEM和KS(水肿)-CEM的0.897和0.899(均p<0.001)。
  • KS-MRI的AUC为0.876,与KS-CEM的0.878相近(p>0.100)。

核心结论

  • CEM的KS在鉴别乳腺肿块方面提供高诊断准确性,与MRI相当;KS(钙化)-CEM结合可疑恶性微钙化可将诊断效能提升至AUC 0.932~0.934,但水肿未能显著提升CEM的KS性能。

研究设计与样本

  • 研究纳入2019年5月至2022年9月间275例乳腺强化肿块患者,按病理诊断分为良性和恶性组,分析CEM与MRI的影像特征,采用配对卡方和Cohen kappa系数比较,并以ROC分析和DeLong检验评估BI-RADS与KS的诊断性能。

关键影像表现/征象

  • 根征、时间-信号强度曲线(TIC/mTIC)、边缘、内部强化模式(IEP)、水肿、表观扩散系数(ADC)值及可疑恶性微钙化在良恶性病灶间差异有统计学意义(均p≤0.011)。
  • 根征和边缘的检出率在CEM与MRI间呈高度一致(κ=0.656,κ=0.640),而IEP、TIC/mTIC和水肿一致性差(κ=0.380,κ=0.320,κ=0.324)。

诊断标准与关键数值

  • 全部分析中CEM的KS的AUC为0.897~0.932,高于BI-RADS的0.691(均p<0.001)。
  • KS(钙化)-CEM的AUC为0.932,高于KS-CEM和KS(水肿)-CEM的0.897和0.899(均p<0.001)。
  • 亚组分析中MRI的KS的AUC为0.875~0.876,高于BI-RADS的0.740(均p<0.001)。
  • KS-MRI(0.876)和KS(ADC)-MRI(0.875)与KS-CEM(0.878)和KS(水肿)-CEM(0.870)的AUC相近(均p>0.100)。
  • KS(钙化)-CEM的AUC为0.934,略高于KS-MRI(0.876)和KS(ADC)-MRI(0.875),但差异无统计学意义(p=0.051;p=0.071)。

临床应用与阅片要点

  • CEM的KS可用于乳腺肿块的鉴别诊断,其诊断准确性与MRI相当。
  • 应用KS(钙化)-CEM并结合可疑恶性微钙化可提高诊断效能。
  • 使用CEM的KS时,水肿对性能的提升不显著。
  • CEM可能为乳腺肿块患者提供替代选择,尤其适用于有MRI禁忌证的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The Kaiser score (KS) is a simple and intuitive machine-learning derived decision rule for characterizing breast lesions in a clinical setting and screening for breast cancer. The present study aims to investigate the applicability of the KS for contrast-enhanced mammography (CEM) in breast masses, and to compare its diagnostic accuracy with magnetic resonance imaging (MRI). CEM may provide an alternative option for patients with breast masses, especially for those with MRI contraindications.

MATERIALS AND METHODS: Two hundred and seventy-five patients with breast enhanced masses were included in the study from May 2019 to September 2022. Patients were further divided into benign and malignant groups based on pathological diagnosis. The CEM and MRI imaging characteristics of these two groups were analyzed statistically. The paired chi-square and Cohen's kappa coefficient (κ) analysis were used to compare imaging characteristics between CEM and MRI. The Breast Imaging Reporting and Data System (BI-RADS) and KS for CEM and MRI were evaluated based on imaging characteristics. The diagnostic performance of BI-RADS and KS for CEM and MRI was assessed and compared using receiver operating characteristic (ROC) analysis and DeLong's test.

RESULTS: The imaging characteristics of root sign, time-signal intensity curve (TIC/mTIC), margin, internal enhancement pattern (IEP), edema, apparent diffusion coefficient (ADC) values, and suspicious malignant microcalcifications showed significant differences between benign and malignant lesions (all p ≤ 0.011). The detection rate of root sign and margin showed substantial agreement between CEM and MRI (κ = 0.656, κ = 0.640), but IEP, TIC/mTIC, and edema showed poor agreement (κ = 0.380, κ = 0.320, κ = 0.324). For all lesion analyses, the area under the curves (AUCs) of the KS (0.897 ∼ 0.932) were higher than that of BI-RADS (0.691) in CEM (all p < 0.001). The AUC of KS (calcification)-CEM (0.932) was higher than those of both KS-CEM and KS (edema)-CEM (0.897 and 0.899) (all p < 0.001). For subgroup analyses, the AUCs of the KS (0.875 ∼ 0.876) were higher than that of BI-RADS (0.740) in MRI (all p < 0.001). The AUCs of KS-MRI (0.876) and KS (ADC)-MRI (0.875) were similar to those of KS-CEM (0.878) and KS (edema)-CEM (0.870) (all p > 0.100). The AUC of KS (calcification)-CEM (0.934) was slightly higher than those of both KS-MRI (0.876) and KS (ADC)-MRI (0.875), but no significant difference was observed (p = 0.051; p = 0.071).

CONCLUSION: The KS for CEM provided high diagnostic accuracy in distinguishing breast masses, comparable to that of MRI. The application of KS (calcification)-CEM combined with suspicious malignant microcalcifications can improve diagnostic efficiency with an AUC of 0.932 ∼ 0.934. However, edema did not significantly improve performance when using the KS for CEM.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Hua B, Yang G, Wang Y, et al. Diagnostic performance of the Kaiser score for contrast-enhanced mammography and magnetic resonance imaging in breast masses: A Comparative Study. Acad Radiol. 2024. PMID: 39395886. doi:10.1016/j.acra.2024.09.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。